Ivisense hypoxia ca ix 680 sonde fluorescente (hypoxysense)x 1 pcs
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
Points clés
In cancer, hypoxia occurs in tumors as a result of the poor ability of their disorganized vascular networks to deliver blood borne oxygen. IVISense Hypoxia CA IX 680 fluorescent imaging probe detects the tumor cell surface expression of carbonic anhydrase 9 (CA IX) protein, which increases in hypoxic regions within many tumors, especially in cervical, colorectal, non-small cell lung tumors. Pairing IVISense Hypoxia CA IX 680 agent with optical fluorescent imaging technology allows you to image and quantitate tumor sub-regions undergoing hypoxia-related changes, non-invasively and in vivo.
Garantie
Garantie 0 Mois
Description
In cancer, hypoxia occurs in tumors as a result of the poor ability of their disorganized vascular networks to deliver blood borne oxygen. IVISense Hypoxia CA IX 680 fluorescent imaging probe detects the tumor cell surface expression of carbonic anhydrase 9 (CA IX) protein, which increases in hypoxic regions within many tumors, especially in cervical, colorectal, non-small cell lung tumors. Pairing IVISense Hypoxia CA IX 680 agent with optical fluorescent imaging technology allows you to image and quantitate tumor sub-regions undergoing hypoxia-related changes, non-invasively and in vivo.
Caractéristiques
- Marque
- REVVITY
- Libellé produit fabricant
- IVISense Hypoxia CA IX 680 Fluorescent Probe (HypoxySense)
- Référence distributeur
- NEV11070
- Référence fabricant
- NEV11070
- Fournisseur
- REVVITY
- Reprise en cas d’erreur client
- non
- Lieu de fabrication
- États-Unis
- Lieu de stockage
- États-Unis
- Domaine de recherche
- biologie cellulaire et microbiologie
- Délai de péremption à la date de livraison
- 6 mois
- Soumis à carboglace
- oui
- Soumis à réglementation
- non
- Température de conservation (°C)
- +2 à +8 °C
- Type d’application
- dépistage néonatal
- Vendu par
- 1 pcs
- Quantité
- N/A
- Nomenclature Nacres
- NA.83
- Nomenclature CEA
- SGP01
- Nomenclature IRSN
- 273
- Nomenclature INSERM
- NA.NA83
- Nomenclature CNRS
- NA83
- Nomenclature CHU
- 18.551
- Nomenclature DGOS
- LD11AOOO